Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,10119,120 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Lactate production by tumor associated macrophages promotes tumorigenesis
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2026

ABSTRACT Tumor-associated macrophages (TAMs) are the most prevalent immune cell in the tumor microenvironment.TAMs adopt an M2-like phenotype that supports angiogenesis, attenuates...

$5.69M
USD
Completed NON-SBIR/STTR RPGS
Pathogenetic roles of USO1 in leukemogenesis
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2023

PROJECT SUMMARY B-acute lymphoblastic leukemia (B-ALL) is the most common malignancy in children.The protein USO1 is specifically overexpressed in B-acute lymphoblastic leukemia (B...

$780K
USD
Completed OTHER RESEARCH-RELATED
PRECISE - a PErsonalized Risk Score for gastrIc CancEr
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

The National Cancer Institute has called for eliminating disparities in cancer morbidity and mortality through the use of Data Science.Gastric cancer remains one of the most unequa...

$1.88M
USD
Completed OTHER RESEARCH-RELATED
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populations
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Tobacco is the leading cause of preventable death and disease and is linked to approximately 20 cancers. The rate of decline of tobacco use has been lower...

$1.38M
USD
Completed NON-SBIR/STTR RPGS
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY Activating KRAS mutations, altered metabolism, and an immunosuppressive tumor microenvironment are all hallmarks of pancreatic ductal adenocarcinoma (PDAC).The rece...

$6.34M
USD
Completed TRAINING, INDIVIDUAL
Engineering Hybrid SynNotch CAR Receptors to Enhance Cell Therapies for Cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2024

Chimeric Antigen T Cell (CAR-T) therapies, which redirect a patient?s own T cells towards their cancer, are very promising therapies for difficult to treat and refractory cancers.W...

$414.2K
USD
Completed TRAINING, INDIVIDUAL
The Mitochondrial Calcium Uniporter in Pancreatic Cancer Development, Metastasis, and Treatment
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

Summary: Pancreatic adenocarcinoma (PDAC) is a particularly lethal form of cancer which kills over 40,000 Americans every year. PDAC is most often diagnosed when disease is advance...

$659.9K
USD
Completed TRAINING, INDIVIDUAL
Identifying the Role of Tumor Cell Intrinsic DNMT1 in Anti-Tumor Immunity in Pancreatic Ductal Adenocarcinoma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary Pancreatic ductal adenocarcinoma (PDAC) is currently the third leading cause of cancer-related death in the United States.The five-year survival rate of less than n...

$510.4K
USD
Completed TRAINING, INDIVIDUAL
Elucidating the role of somatic 3’UTR mutations in prostate cancer pathogenesis
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Research Center United States 2021 – 2023

PROJECT SUMMARY Prostate cancer is the second most common cause of cancer mortality in US men due to our poor understanding and treatment of metastatic, castration-resistant prosta...

$404.4K
USD
Completed TRAINING, INDIVIDUAL
Investigating a Wnt-telomere feedback loop in the colorectal adenoma-carcinoma sequence
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

ABSTRACT: Colorectal adenocarcinoma (CRC) is a leading cause of cancer deaths globally.CRC tumorigenesis proceeds through a model of stepwise transformation of the colonic epitheli...

$460.4K
USD
Completed NON-SBIR/STTR RPGS
A sequential therapeutic strategy of senescence induction and senolytics for elimination of surviving residual breast tumor cells
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2026

Abstract/Summary Chemotherapy and radiation can induce breast tumors to enter a prolonged state of growth arrest with characteristics of senescence.A senescent-like state is also c...

$5.09M
USD
Completed TRAINING, INDIVIDUAL
Characterizing the role of SRCAP in Epidermal Homeostasis and Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE Northwestern University United States 2021 – 2025

Project Summary/Abstract Cutaneous squamous cell carcinoma (cSCC) is the second most common malignancy, disfiguring one million and killing 15,000 people per year in the United Sta...

$412.5K
USD
Completed OTHER RESEARCH-RELATED
Cancer Stem Cells: Advances in Biology and Clinical Translation
NATIONAL CANCER INSTITUTE Keystone Symposia United States 2021 – 2022

ABSTRACT Support is requested for a Keystone Symposia conference entitled Cancer Stem Cells: Advances in Biology and Clinical Translation, organized by Drs. Irene Oi Lin Ng, Xin We...

$50K
USD
Completed NON-SBIR/STTR RPGS
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2025

Clinical radiation therapy is a noninvasive means to mitigate cancer progression, which is prescribed for more than 50% of prostate cancer patients.Development of radiation technol...

$6.91M
USD
Completed TRAINING, INDIVIDUAL
Elucidating the Role of C16orf72 in the Cellular Stress Response Network
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

PROJECT SUMMARY A hallmark of cancer is the ability of malignant cells to maintain viability in the face of stressors such as aneuploidy, nutrient scarcity, and xenobiotic compound...

$510.4K
USD
Completed TRAINING, INDIVIDUAL
Frequency and consequences of chromosome missegregation in breast cancer
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2023

PROJECT SUMMARY Research.Chromosomal instability (CIN) ? observed as the first cancer hallmark over 100-years ago ? is characterized by the persistent loss and gain of whole chromo...

$331.3K
USD
Completed NON-SBIR/STTR RPGS
Small molecule probes of MYC stability and function intumorigenesis
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

ABSTRACT MYC oncoproteins (including c-MYC, L-MYC and N-MYC) play critical roles in the initiation, progression and recurrence of many human malignancies. Extensive studies indicat...

$5.67M
USD
Completed TRAINING, INDIVIDUAL
Dissecting the Gut Microbiota for Immune Checkpoint Blockade (ICB) - Resisting Microbes and Exploring the Generalizability of Microbiota-ICB Studies
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2025

PROJECT SUMMARY Immune checkpoint blockade (ICB) has yielded durable tumor regression and stabilized disease in 10-30% of patients for a range of solid and hematological malignanci...

$480.4K
USD
Completed NON-SBIR/STTR RPGS
XPO1 inhibitors Selinexor and Eltanexor in Combination with Venetoclax and Decitabine (ASTX727) in AML
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2022

a) Project Summary Our studies have shown that the nuclear export inhibitors selinexor and eltanexor are highly active against AML cells and leukemia initiating cells (LICs) in pat...

$1.25M
USD
Completed NON-SBIR/STTR RPGS
Integration of single cell sequencing as a biomarker of PARP inhibitor response for IDH1 and IDH2 mutated AML and MDS
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2022

Project Summary/Abstract Meningioma is the most common intracranial tumor and affects approximately 150,000 individuals in the USA.Approximately 10-20% of them will eventually deve...

$1.24M
USD